Sofinnova Partners Are Redefining And Disobeying The Venture Investment Commandments

Sofinnova Partners has played a key role in defining the medtech investment space for the past 50 years, helping bring to market a plethora of life-saving technologies, even when they appear, initially, to be risky.  

“Thou shalt not invest in capital equipment is a mantra for most investors,” according to Antoine Papiernik, chair and managing partner at Sofinnova Partners.

And yet, since joining the fund in 1997, Papiernik – and Sofinnova as a whole – has defied this commandment and has repeatedly invested in, what would appear from the...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on In Vivo for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from VC Playbook

More from Growth